LC
BIVV

Landaas & Company’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Landaas & Company’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$5K – 349
2017
Q4 		$5K Hold
100
– – ﹤0.01% 289
2017
Q3 		$6K Buy
+100
New +$5.86K 0.01% 285

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Landaas & Company's BIVV Position: Q1 2018 in Review

Landaas & Company sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 100 shares — an estimated $5K sold.

Landaas & Company first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $6K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Landaas & Company reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Landaas & Company sold 100 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $5K.
  • Landaas & Company first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Landaas & Company's Bioverativ Inc. Common Stock position peaked at $6K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Landaas & Company's 13F filing for Q1 2018, filed 14 May 2018.